Tower Research Capital LLC (Trc) Standard Biotools Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 25,454 shares of LAB stock, worth $31,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,454
Previous 36,661
30.57%
Holding current value
$31,562
Previous $43,000
23.26%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding LAB
# of Institutions
163Shares Held
284MCall Options Held
59.7KPut Options Held
18.7K-
Casdin Capital, LLC New York, NY77.6MShares$96.2 Million13.74% of portfolio
-
Viking Global Investors LP58.7MShares$72.7 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$21.4 Million0.0% of portfolio
-
Mak Capital One LLC New York, NY15.9MShares$19.8 Million3.18% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $97.5M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...